Myocardial fibrosis in Eisenmenger syndrome: a descriptive cohort study exploring associations of late gadolinium enhancement with clinical status and survival

[1]  L. Anderson,et al.  The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure. , 2016, Cardiac failure review.

[2]  K. Dimopoulos,et al.  B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy , 2012, Heart.

[3]  R. Mohiaddin,et al.  Cardiovascular magnetic resonance in pulmonary hypertension , 2012, Journal of Cardiovascular Magnetic Resonance.

[4]  Michael Jerosch-Herold,et al.  Quantification of Diffuse Myocardial Fibrosis and Its Association With Myocardial Dysfunction in Congenital Heart Disease , 2010, Circulation. Cardiovascular imaging.

[5]  M. Sheppard,et al.  Understanding late gadolinium enhancement in pulmonary hypertension. , 2010, Circulation. Cardiovascular imaging.

[6]  T. Geva,et al.  Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation. , 2010, Journal of the American College of Cardiology.

[7]  Idith Haber,et al.  Effects of Regional Dysfunction and Late Gadolinium Enhancement on Global Right Ventricular Function and Exercise Capacity in Patients With Repaired Tetralogy of Fallot , 2009, Circulation.

[8]  N. Best,et al.  Prevalence, Predictors, and Prognostic Value of Renal Dysfunction in Adults With Congenital Heart Disease , 2008, Circulation.

[9]  J. Cohn.  Myocardial structural effects of aldosterone receptor antagonism in heart failure. , 2007, Journal of the American College of Cardiology.

[10]  M. Rubens,et al.  Pulmonary arterial thrombosis in eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity. , 2007, Journal of the American College of Cardiology.

[11]  R. Gilkeson,et al.  Evaluation of right ventricular fibrosis in adult congenital heart disease using gadolinium-enhanced magnetic resonance imaging: initial experience in patients with right ventricular loading conditions. , 2006, Congenital heart disease.

[12]  M. Gatzoulis,et al.  Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. , 2006, Journal of the American College of Cardiology.

[13]  K. Dimopoulos,et al.  Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. , 2006, European heart journal.

[14]  D. Pennell,et al.  Ventricular Fibrosis Suggested by Cardiovascular Magnetic Resonance in Adults With Repaired Tetralogy of Fallot and Its Relationship to Adverse Markers of Clinical Outcome , 2006, Circulation.

[15]  P. Poole‐Wilson,et al.  Exercise Intolerance in Adult Congenital Heart Disease: Comparative Severity, Correlates, and Prognostic Implication , 2005, Circulation.

[16]  D. Pennell,et al.  Late Gadolinium Enhancement Cardiovascular Magnetic Resonance of the Systemic Right Ventricle in Adults With Previous Atrial Redirection Surgery for Transposition of the Great Arteries , 2005, Circulation.

[17]  S. Anker,et al.  Neurohormonal Activation and the Chronic Heart Failure Syndrome in Adults With Congenital Heart Disease , 2002, Circulation.

[18]  A. Wessel,et al.  Activity of the renin-angiotensin-aldosterone and sympathetic nervous system and their relation to hemodynamic and clinical abnormalities in infants with left-to-right shunts. , 2001, International journal of cardiology.

[19]  A. Woodcock,et al.  Two-, six-, and 12-minute walking tests in respiratory disease. , 1982, British medical journal.